These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 1890066)
1. Controversies in the multimodality management of head and neck cancer. Thomas CR; Taylor SG Hematol Oncol Clin North Am; 1991 Aug; 5(4):769-81. PubMed ID: 1890066 [TBL] [Abstract][Full Text] [Related]
2. Radiotherapy with concomitant chemotherapy for head and neck cancer. Vokes EE; Awan AM; Weichselbaum RR Hematol Oncol Clin North Am; 1991 Aug; 5(4):753-67. PubMed ID: 1890065 [TBL] [Abstract][Full Text] [Related]
3. Overview of platinum chemotherapy in head and neck cancer. Forastiere AA Semin Oncol; 1994 Oct; 21(5 Suppl 12):20-7. PubMed ID: 7527591 [TBL] [Abstract][Full Text] [Related]
5. [Role of neoadjuvant chemotherapy for management of resectable head and neck cancer]. Horiuchi M; Tamura Y; Miyake H Gan To Kagaku Ryoho; 1994 Mar; 21(4):417-24. PubMed ID: 8129381 [TBL] [Abstract][Full Text] [Related]
6. Evidence-based radiation oncology in head and neck squamous cell carcinoma. Corvò R Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300 [TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy as initial treatment for advanced head and neck cancer: a model for the multidisciplinary treatment of solid tumors. Clark JR; Fallon BG; Frei E Important Adv Oncol; 1987; ():175-95. PubMed ID: 3331380 [TBL] [Abstract][Full Text] [Related]
8. [Current status of clinical trials on pre- and postoperative chemotherapy for head and neck cancer]. Inuyama Y; Fukuda S; Horiuchi M Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():338-47. PubMed ID: 7986113 [TBL] [Abstract][Full Text] [Related]
9. [Head and neck cancer]. Inuyama Y; Fukuda S; Fujii M Gan To Kagaku Ryoho; 1995 May; 22(6):732-8. PubMed ID: 7755381 [TBL] [Abstract][Full Text] [Related]
10. Organ preservation in multimodality therapy of head and neck cancer. Urba S; Wolf GT Hematol Oncol Clin North Am; 1991 Aug; 5(4):713-24. PubMed ID: 1890062 [TBL] [Abstract][Full Text] [Related]
11. Paradigm shift in the treatment of head and neck cancer: the role of neoadjuvant chemotherapy. Posner MR Oncologist; 2005; 10 Suppl 3():11-9. PubMed ID: 16368867 [TBL] [Abstract][Full Text] [Related]
12. Future chemotherapy and radiotherapy options in head and neck cancer. Merlano M; Mattiot VP Expert Rev Anticancer Ther; 2006 Mar; 6(3):395-403. PubMed ID: 16503856 [TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. Budach W; Hehr T; Budach V; Belka C; Dietz K BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551 [TBL] [Abstract][Full Text] [Related]
14. Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer? Adelstein DJ; Leblanc M J Clin Oncol; 2006 Jun; 24(17):2624-8. PubMed ID: 16763275 [TBL] [Abstract][Full Text] [Related]
15. Sequential combined modality therapy for stage III non-small cell lung cancer. Vokes EE Hematol Oncol Clin North Am; 1990 Dec; 4(6):1133-42. PubMed ID: 1962780 [TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience. Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834 [TBL] [Abstract][Full Text] [Related]
17. [Role of Chemotherapy in head and neck cancer]. Kohno N; Kitahara S Gan To Kagaku Ryoho; 2001 Apr; 28(4):448-53. PubMed ID: 11329777 [TBL] [Abstract][Full Text] [Related]
18. Nonsurgical management of malignant thymoma. Hejna M; Haberl I; Raderer M Cancer; 1999 May; 85(9):1871-84. PubMed ID: 10223225 [TBL] [Abstract][Full Text] [Related]
19. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis. Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114 [TBL] [Abstract][Full Text] [Related]